References
Brand PLP, Roorda RJ. Drug delivery in pediatric patients with asthma. Spacer devices vs nebulizers for β2 agonists. Am J Drug Deliv 2003; 1(1): 61–70
Biggart E, Bush A. Antiasthmatic drug delivery in children. Pediatr Drugs 2002; 4: 85–93
Rubilar L, Castro-Rodriguez JA, Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol 2000; 29(4): 264–9
Wildhaber JH, Dore ND, Wilson JM, et al. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999; 135(1): 28–33
Wildhaber JH, Devadason SG, Hayden MJ, et al. Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers. Pediatr Pulmonol 1997; 23(3): 212–6
Kerem E, Levison H, Schuh S, et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993; 123: 313–7
Schuh S, Johnson DW, Stephens D, et al. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr 1999; 135: 22–7
Chou KJ, Cunningham SJ, Crain EF. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr AdolescMed 1995; 149: 201–5
British Thoracic Society. British guidelines on asthma management; 1995 review and position statement. Thorax 1997; 52 Suppl. 1: S1–24
Powell CVE, Maskell GR, Marks MK, et al. Successful implementation of spacer treatment guideline for acute asthma. Arch Dis Child 2001; 84: 142–6
Barry PW, O’Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur Respir J. 1997; 10(6): 1345–8
Bisgaard H. Delivery of inhaled medication to children. J Asthma 1997; 34: 443–67
Rights and permissions
About this article
Cite this article
Metered-dose inhalers with spacer devices are the system of choice for delivering short-acting β2-agonists to children with asthma. Drugs Ther. Perspect 19, 23–26 (2003). https://doi.org/10.2165/00042310-200319100-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200319100-00008